BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37986082)

  • 1. Effect of initial recurrence site on the prognosis of different tissue types of non-small cell lung cancer: a retrospective cohort study.
    Li Y; Liu L; You R; Li Q; Jiang Z; Pu H; Li Z; Chen X
    World J Surg Oncol; 2023 Nov; 21(1):360. PubMed ID: 37986082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of the initial recurrence site on prognosis after radical surgery for colorectal cancer: a retrospective cohort study.
    Pu H; Chen Y; Shen R; Zhang Y; Yang D; Liu L; Dong X; Yang G
    World J Surg Oncol; 2023 Apr; 21(1):137. PubMed ID: 37101165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative predictors for recurrence sites associated with poor post-recurrence survival after surgery of non-small cell lung cancer: a multicenter study.
    Isaka T; Adachi H; Murakami K; Miura J; Kikunishi N; Shigeta N; Kudo Y; Miyata Y; Okada M; Ikeda N; Ito H
    BMC Cancer; 2023 Nov; 23(1):1064. PubMed ID: 37926846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of post-recurrence survival in patients with non-small-cell lung cancer initially completely resected.
    Takahashi Y; Horio H; Hato T; Harada M; Matsutani N; Kawamura M
    Interact Cardiovasc Thorac Surg; 2015 Jul; 21(1):14-20. PubMed ID: 25878187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid predominant histologic subtype and early recurrence predict poor postrecurrence survival in patients with stage I lung adenocarcinoma.
    Luo J; Wang R; Han B; Zhang J; Zhao H; Fang W; Luo Q; Yang J; Yang Y; Zhu L; Chen T; Cheng X; Huang Q; Wang Y; Zheng J; Chen H
    Oncotarget; 2017 Jan; 8(4):7050-7058. PubMed ID: 27732964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the initial site of recurrence on prognosis after curative surgery for primary lung cancer.
    Isaka T; Ito H; Nakayama H; Yokose T; Saito H; Masuda M
    Eur J Cardiothorac Surg; 2022 Mar; 61(4):778-786. PubMed ID: 34686875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Factors for Local and Distant Recurrence After Surgical Treatment in Patients With Non-Small-Cell Lung Cancer.
    Dziedzic DA; Rudzinski P; Langfort R; Orlowski T;
    Clin Lung Cancer; 2016 Sep; 17(5):e157-e167. PubMed ID: 26831834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proposal on incorporating lymphovascular invasion as a T-descriptor for stage I lung cancer.
    Wang S; Zhang B; Qian J; Qiao R; Xu J; Zhang L; Zhao Y; Zhang Y; Wang R; Zhao R; Han B
    Lung Cancer; 2018 Nov; 125():245-252. PubMed ID: 30429028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors and the significance of treatment after recurrence in completely resected stage I non-small cell lung cancer.
    Shimada Y; Saji H; Yoshida K; Kakihana M; Honda H; Nomura M; Usuda J; Kajiwara N; Ohira T; Ikeda N
    Chest; 2013 Jun; 143(6):1626-1634. PubMed ID: 23348916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact and initial recurrence site of lymphovascular and visceral pleural invasion in surgically resected stage I non-small-cell lung carcinoma.
    Yanagawa N; Shiono S; Abiko M; Ogata SY; Sato T; Tamura G
    Eur J Cardiothorac Surg; 2013 Sep; 44(3):e200-6. PubMed ID: 23766428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Pleural Lavage Cytology Both Before and After Lung Resection on Recurrence of Non-Small Cell Lung Cancer.
    Shoji F; Yamazaki K; Kouso H; Mori R; Takeo S
    Ann Thorac Surg; 2016 Jun; 101(6):2141-6. PubMed ID: 27012585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term survival outcome after postoperative recurrence of non-small-cell lung cancer: who is 'cured' from postoperative recurrence?
    Sekihara K; Hishida T; Yoshida J; Oki T; Omori T; Katsumata S; Ueda T; Miyoshi T; Goto M; Nakasone S; Ichikawa T; Matsuzawa R; Aokage K; Goto K; Tsuboi M
    Eur J Cardiothorac Surg; 2017 Sep; 52(3):522-528. PubMed ID: 28482033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative oligo-recurrence of non-small-cell lung cancer: clinical features and survival†.
    Hishida T; Yoshida J; Aokage K; Nagai K; Tsuboi M
    Eur J Cardiothorac Surg; 2016 Mar; 49(3):847-53. PubMed ID: 26201958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KRAS genetic variant as a prognostic factor for recurrence in resectable non-small cell lung cancer.
    Sullivan I; Salazar J; Arqueros C; Andrés M; Sebio A; Majem M; Szafranska J; Martínez E; Páez D; López-Pousa A; Baiget M; Barnadas A
    Clin Transl Oncol; 2017 Jul; 19(7):884-890. PubMed ID: 28150169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
    Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified Glasgow Prognostic Score at Recurrence Predicts Poor Survival in Resected Non-Small Cell Lung Cancer (NSCLC) Patients.
    Lv Y; Pan Y; Dong C; Liu P; Zhang C; Xing D
    Med Sci Monit; 2017 Aug; 23():3780-3788. PubMed ID: 28775246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supraclavicular lymph node incisional biopsies have no influence on the prognosis of advanced non-small cell lung cancer patients: a retrospective study.
    Dong S; Zhao N; Deng W; Sun HW; Niu FY; Yang JJ; Zhong WZ; Li F; Yan HH; Xu CR; Zhang QY; Yang XN; Liao RQ; Nie Q; Wu YL
    World J Surg Oncol; 2017 Jan; 15(1):12. PubMed ID: 28069039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of adjuvant chemotherapy on survival of patients with stage IB non-small cell lung cancer with visceral pleural invasion.
    Xie J; Zhang X; Hu S; Peng WD; Xu B; Li Y; Zhang SJ; Li Q; Li C
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2231-2239. PubMed ID: 32533405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracapsular extension is a powerful prognostic factor in stage IIA-IIIA non-small cell lung cancer patients with completely resection.
    Liu W; Shao Y; Guan B; Hao J; Cheng X; Ji K; Wang K
    Int J Clin Exp Pathol; 2015; 8(9):11268-77. PubMed ID: 26617851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors for post-recurrence survival in patients with completely resected Stage III (N2) non-small-cell lung cancer.
    Cho S; Yum S; Kim K; Jheon S
    Eur J Cardiothorac Surg; 2018 Sep; 54(3):554-559. PubMed ID: 29490049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.